Funding for this research was provided by:
AstraZeneca K.K.
Article History
Received: 23 December 2024
Accepted: 12 June 2025
First Online: 2 August 2025
Declarations
:
: Hiroshi Kitagawa, Kazuki Fukuzawa, Masaki Tanaka are employed by AstraZeneca K.K.
: This observational study was performed in accordance with the Declaration of Helsinki and all applicable regulations in Japan. The study was approved by an independent ethics committee (MINS ethics committee; approval number: 240216; date of approval: June 6, 2024).
: Owing to the retrospective nature of this observational study, and the use of commercially available anonymized administrative data, it was not necessary to obtain informed consent in accordance with Japanese regulations.